ZA906451B - Purine derivatives,process for their preparation,pharmaceutical compositions and intermediates - Google Patents

Purine derivatives,process for their preparation,pharmaceutical compositions and intermediates

Info

Publication number
ZA906451B
ZA906451B ZA906451A ZA906451A ZA906451B ZA 906451 B ZA906451 B ZA 906451B ZA 906451 A ZA906451 A ZA 906451A ZA 906451 A ZA906451 A ZA 906451A ZA 906451 B ZA906451 B ZA 906451B
Authority
ZA
South Africa
Prior art keywords
preparation
intermediates
pharmaceutical compositions
purine derivatives
hydroxyprop
Prior art date
Application number
ZA906451A
Other languages
English (en)
Inventor
Michael Raymond Harnden
Raymond Harnden Michael
Paul Graham Wyatt
Graham Wyatt Paul
Leslie John Arthur Jennings
John Arthur Jennings Leslie
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA906451B publication Critical patent/ZA906451B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Sub-Exchange Stations And Push- Button Telephones (AREA)
  • Jib Cranes (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
ZA906451A 1989-08-17 1990-08-15 Purine derivatives,process for their preparation,pharmaceutical compositions and intermediates ZA906451B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918827A GB8918827D0 (en) 1989-08-17 1989-08-17 Novel compounds

Publications (1)

Publication Number Publication Date
ZA906451B true ZA906451B (en) 1991-07-31

Family

ID=10661797

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906451A ZA906451B (en) 1989-08-17 1990-08-15 Purine derivatives,process for their preparation,pharmaceutical compositions and intermediates

Country Status (19)

Country Link
EP (1) EP0413544B1 (hu)
JP (1) JP3072600B2 (hu)
KR (1) KR910004621A (hu)
CN (1) CN1049502A (hu)
AT (1) ATE147075T1 (hu)
AU (1) AU630223B2 (hu)
CA (1) CA2023291A1 (hu)
DE (1) DE69029547T2 (hu)
FI (1) FI904066A0 (hu)
GB (1) GB8918827D0 (hu)
HU (1) HU207519B (hu)
IE (1) IE902959A1 (hu)
MA (1) MA21932A1 (hu)
NO (1) NO903583L (hu)
NZ (1) NZ234918A (hu)
PL (3) PL286529A1 (hu)
PT (1) PT95013B (hu)
ZA (1) ZA906451B (hu)
ZW (1) ZW12990A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107896D0 (en) * 1991-04-13 1991-05-29 Smithkline Beecham Plc Pharmaceuticals
WO1994022864A1 (en) * 1993-03-30 1994-10-13 Sterling Winthrop Inc. Acyclic nucleoside analogs and oligonucleotide sequences containing them
GB9402161D0 (en) 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
CN109289078B (zh) * 2018-11-02 2020-06-19 广东药科大学 一种长效抑菌创可贴

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507606D0 (en) * 1985-03-23 1985-05-01 Beecham Group Plc Process
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds
US4965270A (en) * 1987-05-30 1990-10-23 Beecham Group P.L.C. Purine derivatives
GB8713695D0 (en) * 1987-06-11 1987-07-15 Beecham Group Plc Process
GB8712744D0 (en) * 1987-05-30 1987-07-01 Beecham Group Plc Active compounds
GB8724765D0 (en) * 1987-10-22 1987-11-25 Beecham Group Plc Process

Also Published As

Publication number Publication date
NO903583L (no) 1991-02-18
PT95013B (pt) 1997-05-28
JP3072600B2 (ja) 2000-07-31
ATE147075T1 (de) 1997-01-15
GB8918827D0 (en) 1989-09-27
PT95013A (pt) 1991-04-18
HU905025D0 (en) 1991-01-28
ZW12990A1 (en) 1991-05-08
CA2023291A1 (en) 1991-02-18
CN1049502A (zh) 1991-02-27
KR910004621A (ko) 1991-03-29
PL290988A1 (en) 1992-03-23
HUT54689A (en) 1991-03-28
PL290987A1 (en) 1992-03-23
AU6101390A (en) 1991-02-21
HU207519B (en) 1993-04-28
JPH03118382A (ja) 1991-05-20
DE69029547D1 (de) 1997-02-13
IE902959A1 (en) 1991-02-27
EP0413544B1 (en) 1997-01-02
PL286529A1 (en) 1991-12-02
DE69029547T2 (de) 1997-06-26
AU630223B2 (en) 1992-10-22
EP0413544A2 (en) 1991-02-20
FI904066A0 (fi) 1990-08-16
NO903583D0 (no) 1990-08-15
NZ234918A (en) 1993-04-28
MA21932A1 (fr) 1991-04-01
EP0413544A3 (en) 1992-07-08

Similar Documents

Publication Publication Date Title
AU569462B2 (en) Antiviral purine derivatives
IL88755A (en) (1:, 2, 3:)-3-substituted-2- hydroxycyclo- butanemethanol derivatives and pharmaceutical and veterinary compositions containing the same
HUT40633A (en) Process for production of bicyclically condensated derivatives of oxasole and triasole-amin,substituated by 4-piperimidil-alkyl group
IE861875L (en) Poly-4-aminopyrrole-2-carboxamido derivatives
EP0413544A3 (en) Purine derivatives, process for their preparation, pharmaceutical compositions and intermediates
ES8704914A1 (es) Un procedimiento para la preparacion de derivados de 1,5-benzotiazepina'
AU2631188A (en) 9-(2-(Phosphonomethoxy)Ethoxy) Purine derivatives, intermediates and use as pharmaceuticals
ES8707217A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina
HU902531D0 (en) Process for producing derivatives of purinyl- and pyrimidnyl-tetrahydrofurane and containing them pharmaceutical preparatives
IL87107A0 (en) Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.